Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Progress in neurobiology

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pneurobio.2014.07.004PMID 25084549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models

  2015cited by this paper
• Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling.

  2014cited by this paper
• Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

  2014cited by this paper
• Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

  2014cited by this paper
• Wnt signaling in the nervous system and in Alzheimer's disease.

  2014cited by this paper
• Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

  2014cited by this paper
• Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

  2014cited by this paper
• Meta-Analysis: Overweight, Obesity, and Parkinson's Disease

  2014cited by this paper
• The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

  2014cited by this paper
• In vivo Activation of Wnt Signaling Pathway Enhances Cognitive Function of Adult Mice and Reverses Cognitive Deficits in an Alzheimer's Disease Model

  2014cited by this paper
• First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

  2014cited by this paper
• Brain metabolite clearance: impact on Alzheimer’s disease

  2014cited by this paper
• Obesity--a neuropsychological disease? Systematic review and neuropsychological model.

  2014cited by this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cited by this paper
• Malondialdehyde regulates glucose-stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway.

  2014cited by this paper
• The paradox of neuronal insulin action and resistance in the development of aging‐associated diseases

  2014cited by this paper
• Wnt Signaling in Skeletal Muscle Dynamics: Myogenesis, Neuromuscular Synapse and Fibrosis

  2014cited by this paper
• How does brain insulin resistance develop in Alzheimer's disease?

  2014cited by this paper
• Role of Sirt1 During the Ageing Process: Relevance to Protection of Synapses in the Brain

  2014cited by this paper
• Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.

  2014cited by this paper
• Functional Analysis LRP6 Novel Mutations in Patients with Coronary Artery Disease

  2014cited by this paper
• Signaling pathway cross talk in Alzheimer’s disease

  2014cited by this paper
• Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

  2014cited by this paper
• Body mass index and brain structure in healthy children and adolescents

  2014cited by this paper
• Wnt/β-catenin signaling in Alzheimer's disease.

  2014cited by this paper
• Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

  2014cited by this paper
• Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease.

  2014cited by this paper
• Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications

  2014cited by this paper
• Experimental Induction of Type 2 Diabetes in Aging-Accelerated Mice Triggered Alzheimer-Like Pathology and Memory Deficits

  2014cited by this paper
• Association of diabetes with amnestic and nonamnestic mild cognitive impairment

  2014cited by this paper
• Estado nutricional, síndrome metabólico y resistencia a la insulina en niños de Santiago, Chile

  2013cited by this paper
• The genetics of NAFLD

  2013cited by this paper
• The risk of maternal obesity to the long‐term health of the offspring

  2013cited by this paper
• Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice.

  2013cited by this paper
• Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease

  2013cited by this paper
• FTO, obesity and the adolescent brain.

  2013cited by this paper
• Rare Nonconservative LRP6 Mutations Are Associated with Metabolic Syndrome

  2013cited by this paper
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013cited by this paper
• Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.

  2013cited by this paper
• Peroxisome Proliferators Reduce Spatial Memory Impairment, Synaptic Failure, and Neurodegeneration in Brains of a Double Transgenic Mice Model of Alzheimer's Disease

  2013cited by this paper
• Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling.

  2013cited by this paper
• Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.

  2013cited by this paper
• Alzheimer's disease and diabetes: new insights and unifying therapies.

  2013cited by this paper
• Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.

  2013cited by this paper
• Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.

  2013cited by this paper
• Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

  2013cited by this paper
• Peroxisome Proliferator-activated Receptors and Alzheimer's Disease: Hitting the Blood–Brain Barrier

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

  2013cited by this paper
• Vascular Aspects of Cognitive Impairment and Dementia

  2013cited by this paper
• Genetics of familial and sporadic Alzheimer's disease.

  2013cited by this paper
• Retinal Vessel Abnormalities as a Possible Biomarker of Brain Volume Loss in Obese Adolescents

  2013cited by this paper
• Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice

  2013cited by this paper
• Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease.

  2013cited by this paper
• Maternal obesity affects gene expression and cellular development in fetal brains

  2013cited by this paper
• Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors

  2013cited by this paper
• Targeting the Wnt/frizzled signaling pathway after myocardial infarction: a new tool in the therapeutic toolbox?

  2013cited by this paper
• Genetic insights in Alzheimer's disease.

  2013cited by this paper
• Diabetes: Human β-cell proliferation by promoting Wnt signalling

  2013cited by this paper
• Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes

  2013cited by this paper
• Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.

  2013cited by this paper
• Therapeutic approach for neuronal disease by regulating renin-angiotensin system.

  2013cited by this paper
• Amyloid-&bgr; Peptides Activate &agr;1-Adrenergic Cardiovascular Receptors

  2013cited by this paper
• Insulin resistance: an emerging link in Alzheimer’s disease

  2013cited by this paper
• Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?

  2013cited by this paper
• Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions

  2013cited by this paper
• Mice Deficient in Sfrp1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism, and Enhanced Macrophage Infiltration

  2013cited by this paper
• Octodon degus: A Model for the Cognitive Impairment Associated with Alzheimer's Disease

  2013cited by this paper
• The worldwide economic impact of dementia 2010

  2013cited by this paper
• Advanced BrainAGE in older adults with type 2 diabetes mellitus

  2013cited by this paper
• Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss.

  2013cited by this paper
• Leptin and the brain: then and now.

  2013cited by this paper
• A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease.

  2013cited by this paper
• Maternal Obesity Caused by Overnutrition Exposure Leads to Reversal Learning Deficits and Striatal Disturbance in Rats

  2013cited by this paper
• Maternal obesity induced by a high fat diet causes altered cellular development in fetal brains suggestive of a predisposition of offspring to neurological disorders in later life

  2013cited by this paper
• Amylin deposition in the brain: A second amyloid in Alzheimer disease?

  2013cited by this paper
• Canonical Wnt signaling protects hippocampal neurons from Aβ oligomers: role of non-canonical Wnt-5a/Ca2+ in mitochondrial dynamics

  2013cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• Brain responses to food logos in obese and healthy weight children.

  2013cited by this paper
• WNT signaling in neuronal maturation and synaptogenesis

  2013cited by this paper
• Wnts in adult brain: from synaptic plasticity to cognitive deficiencies

  2013cited by this paper
• Diabetes Augments In Vivo Microvascular Blood Flow Dynamics after Stroke

  2013cited by this paper
• Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

  2013cited by this paper
• Cardiometabolic factors and disease duration in patients with Parkinson's disease.

  2013cited by this paper
• Emerging roles of astrocytes in neural circuit development

  2013cited by this paper
• Sfrp5 correlates with insulin resistance and oxidative stress

  2013cited by this paper
• The Relationship between Executive Function and Obesity in Children and Adolescents: A Systematic Literature Review

  2013cited by this paper
• Insulin Receptor-Overexpressing β-Cells Ameliorate Hyperglycemia in Diabetic Rats through Wnt Signaling Activation

  2013cited by this paper
• Upregulation of genes related to bone formation by γ-amino butyric acid and γ-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats

  2013cited by this paper
• Metabolic Syndrome and Cognitive Decline in Early Alzheimer's Disease and Healthy Older Adults

  2013cited by this paper
• Angiotensin II–Independent Upregulation of Cyclooxygenase-2 by Activation of the (Pro)Renin Receptor in Rat Renal Inner Medullary Cells

  2013cited by this paper
• Is obesity associated with a decline in intelligence quotient during the first half of the life course?

  2013cited by this paper
• [Nutritional status, metabolic syndrome and insulin resistance in children from Santiago (Chile)].

  2013cited by this paper
• Wnt/β-Catenin Signaling Protects Mouse Liver against Oxidative Stress-induced Apoptosis through the Inhibition of Forkhead Transcription Factor FoxO3*

  2013cited by this paper
• Alzheimer disease and diabetes mellitus: do they have anything in common?

  2013cited by this paper
• Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?

  2013cited by this paper
• Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice.

  2013cited by this paper
• Wnt your brain be inflamed? Yes, it Wnt!

  2013cited by this paper
• Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

  2013cited by this paper
• Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.

  2013cited by this paper

• Cornus mas ameliorates AlCl3-induced Alzheimer’s disease in rats with metabolic syndrome by regulating inflammation and oxidative stress

  2025cites this paper
• Voglibose Attenuates Amyloid Beta–Induced Memory Deficits in a Rodent Model: A Potential Alzheimer’s Therapy via Wnt Signaling Modulation

  2025cites this paper
• Adipokines at the Metabolic–Brain Interface: Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer’s Disease

  2025cites this paper
• Andrographolide modulates glucose metabolism in visceral adipose tissue in an Alzheimer's disease obese mouse model

  2025cites this paper
• Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

  2025cites this paper
• Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseases

  2024cites this paper
• Intergenic Interactions of ESR1, GSTO1 and AGER and Risk of Dementia in Community-Dwelling Elderly (SADEM Study)

  2024cites this paper
• Emerging role of Metformin in Alzheimer's disease: A translational view.

  2024cites this paper
• Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

  2023cites this paper
• Profiling and Cellular Analyses of Obesity-Related circRNAs in Neurons and Glia under Obesity-like In Vitro Conditions

  2023cites this paper
• Menopause and development of Alzheimer’s disease: Roles of neural glucose metabolism and Wnt signaling

  2022cites this paper
• The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

  2022cites this paper
• 1-L Transcription in Alzheimer’s Disease

  2022cites this paper
• The role of Wnt/mTOR signaling in spinal cord injury.

  2022cites this paper
• Inflammation context in Alzheimer’s disease, a relationship intricate to define

  2022cites this paper
• mTOR pathway: A potential therapeutic target for spinal cord injury.

  2021cites this paper
• Direct modulation of the gut microbiota as a therapeutic approach for Alzheimer's disease.

  2021cites this paper
• A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank

  2021cites this paper
• Low‐Density Lipoprotein Receptor‐Related Protein 6 Cell Surface Availability Regulates Fuel Metabolism in Astrocytes

  2021cites this paper
• A global overview of genetically interpretable comorbidities among common diseases in UK Biobank

  2021cites this paper
• Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease

  2021cites this paper
• Repositioning of antidiabetic drugs for Alzheimer’s disease: possibility of Wnt signaling modulation by targeting LRP6 an in silico based study

  2021cites this paper
• Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease

  2021cites this paper
• A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease.

  2021cites this paper
• [Digital health services as a means to control dementia].

  2020cites this paper
• Interleukin-6 Treatment Results in GLUT4 Translocation and AMPK Phosphorylation in Neuronal SH-SY5Y Cells

  2020cites this paper
• Protective effects of Akkermansia muciniphila on cognitive deficits and amyloid pathology in a mouse model of Alzheimer’s disease

  2020cites this paper
• Cardiometabolic Syndrome

  2020cites this paper
• The association of metabolic syndrome and cognitive impairment in Jidong of China: a cross-sectional study

  2020cites this paper
• Octodon degus: a natural model of multimorbidity for ageing research.

  2020cites this paper
• Effect of exenatide, metformin and folic acid on experimentally induced metabolic–cognitive syndrome in rats

  2020cites this paper
• Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder

  2020influential citation
• Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches

  2020cites this paper
• Integrative genomics analysis identifies five promising genes implicated in insomnia risk based on multiple omics datasets

  2020cites this paper
• Lifestyle intervention to prevent Alzheimer’s disease

  2020cites this paper
• Canonical Wnt Signaling Modulates the Expression of Pre- and Postsynaptic Components in Different Temporal Patterns

  2019cites this paper
• Presymptomatic Treatment With Andrographolide Improves Brain Metabolic Markers and Cognitive Behavior in a Model of Early-Onset Alzheimer’s Disease

  2019cites this paper
• Cardiac Abnormalities in Alzheimer Disease: Clinical Relevance Beyond Pathophysiological Rationale and Instrumental Findings?

  2019cites this paper
• APOE ε4 carriers have a greater propensity to glycation and sRAGE which is further influenced by RAGE G82S polymorphism.

  2019cites this paper
• Glucose and white adipose tissue metabolism. Effects of site and sex on the fate of glucose

  2018cites this paper
• Risk of dementia associated with cardiometabolic abnormalities and depressive symptoms: a longitudinal cohort study using the English longitudinal study of ageing

  2018cites this paper
• The involvement of the canonical Wnt‐signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta‐analysis

  2018cites this paper
• Tissue-Specific Metabolomics Analysis Identifies the Liver as a Major Organ of Metabolic Disorders in Amyloid Precursor Protein/Presenilin 1 Mice of Alzheimer's Disease.

  2018cites this paper
• GLP‐1 receptor agonists downregulate aberrant GnT‐III expression in Alzheimer's disease models through the Akt/GSK‐3&bgr;/&bgr;‐catenin signaling

  2018influential citation
• Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.

  2018cites this paper
• Modulation of Glucose Metabolism in Hippocampal Neurons by Adiponectin and Resistin

  2018cites this paper
• L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease

  2018cites this paper
• Application of Metabolomics in Alzheimer’s Disease

  2018cites this paper
• Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus

  2018cites this paper
• Wnt3a ligand facilitates autophagy in hippocampal neurons by modulating a novel GSK-3β-AMPK axis

  2018cites this paper
• Wnt‐induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease

  2018cites this paper
• Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats.

  2018cites this paper
• Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20‐APP transgenic and wild‐type mice

  2018cites this paper
• Arginase as a Potential Target in the Treatment of Alzheimer’s Disease

  2018cites this paper
• Mespilus germanica Flavonoids Attenuate Cognitive Dysfunction in the Streptozotocin-induced Rat Model of Alzheimer's Disease

  2018cites this paper
• Obesity and Metabolic Syndrome Affect the Cholinergic Transmission a nd Cognitive Functions.

  2017cites this paper
• Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?

  2017cites this paper
• Impact of legumes and plant proteins consumption on cognitive performances in the elderly

  2017cites this paper
• Global gene expression changes in the prefrontal cortex of rabbits with hypercholesterolemia and/or hypertension

  2017cites this paper
• Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.

  2017cites this paper
• PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

  2017influential citation
• The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer’s disease model

  2017cites this paper
• Brain glucose metabolism: Role of Wnt signaling in the metabolic impairment in Alzheimer's disease.

  2017influential citation
• Probiotics improve insulin resistance status in an experimental model of Alzheimer’s disease

  2017influential citation
• Effect of Cornus mas fruit flavonoids on memory retention, level of plasma glucose and lipids in an intra- cerebroventricular streptozotocin-induced experimental Alzheimer's disease model in Wistar rats

  2016cites this paper
• Wnt5a Increases the Glycolytic Rate and the Activity of the Pentose Phosphate Pathway in Cortical Neurons

  2016cites this paper
• The early life nutritional environment and early life stress as potential pathways towards the metabolic syndrome in mid-life? A lifecourse analysis using the 1958 British Birth cohort

  2016cites this paper
• Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis*

  2016influential citation
• Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment.

  2016cites this paper
• Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome

  2016cites this paper
• Shengmai Formula Ameliorates Pathological Characteristics in AD C. elegans

  2016cites this paper
• Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer’s Disease

  2016cites this paper
• Epigenetic mechanisms as key regulators in disease: Clinical implications

  2016cites this paper
• Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

  2016cites this paper
• Tanshinone IIA decreases the levels of inflammation induced by A&bgr;1–42 in brain tissues of Alzheimer’s disease model rats

  2016cites this paper
• Revisiting rodent models: Octodon degus as Alzheimer’s disease model?

  2016cites this paper
• Effects of glucose and insulin on secretion of amyloid‐β by human adipose tissue cells

  2016cites this paper
• Modifiable risk factors of Alzheimer's disease and neuroinflammation: what are the links?

  2016cites this paper
• Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease

  2015cites this paper
• Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.

  2015influential citation
• Amyloid β peptide-induced inhibition of endothelial nitric oxide production involves oxidative stress-mediated constitutive eNOS/HSP90 interaction and disruption of agonist-mediated Akt activation

  2015cites this paper
• Amylin at the interface between metabolic and neurodegenerative disorders

  2015cites this paper
• Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?

  2015cites this paper
• The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin.

  2015cites this paper
• Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of Alzheimer's Disease

  2015cites this paper
• Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance.

  2015cites this paper
• Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease.

  2015cites this paper
• Role of Wnt Signaling in Central Nervous System Injury

  2015cites this paper
• Central acylated ghrelin improves memory function and hippocampal AMPK activation and partly reverses the impairment of energy and glucose metabolism in rats infused with β-amyloid.

  2015cites this paper
• Obesity, Metabolic Dysfunction, and Dementia

  2015cites this paper
• Visión panorámica de las enfermedades crónico-degenerativas

  2015cites this paper
• The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease.

  2015cites this paper
• Leptin in Alzheimer's disease.

  2015cites this paper
• Plasma leptin levels and free leptin index in women with Alzheimer's disease.

  2015cites this paper
• Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease

  2015cites this paper
• On the role of 4-hydroxynonenal in health and disease.

  2015cites this paper
• Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer’s Disease

  2015cites this paper
• Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease

  2015cites this paper
• A Human-Based Integrated Framework forAlzheimer’s Disease Research

  2015cites this paper
• Adipobiology of the brain: From brain diabetes to adipose Alzheimer‘s disease

  2015cites this paper